M. Bratti

发表

p53 polymorphism and risk of cervical cancer

M. Carrington, J. Fraumeni, L. Brinton, 1998, Nature.

Can cervicography be improved? An evaluation with arbitrated cervicography interpretations.

Nilanjan Chatterjee, Mark Spitzer, Mark Schiffman, 2002, American journal of obstetrics and gynecology.

Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.

Allan Hildesheim, Rolando Herrero, Mark Schiffman, 2004, Revista panamericana de salud publica = Pan American journal of public health.

A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer.

Guillermo Marshall, Allan Hildesheim, Sholom Wacholder, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

HPV DNA Testing in Cervical Cancer Screening: Results From Women in a High-Risk Province of Costa Rica

S. Wacholder, M. Sherman, M. Schiffman, 2000 .

Comparisons of HPV DNA detection by MY09/11 PCR methods

M. Sherman, P. Castle, R. Burk, 2002, Journal of medical virology.

Soluble Interleukin 2 Receptor Levels and Cervical Neoplasia

M. Sherman, R. Burk, A. Hildesheim, 1999 .

The carcinogenicity of human papillomavirus types reflects viral evolution.

R. DeSalle, S. Wacholder, M. Sherman, 2005, Virology.

Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

S. Wacholder, M. Sherman, M. Schiffman, 2006, Cancer research.

Cytokine and immunoglobulin concentrations in cervical secretions: reproducibility of the Weck-cel collection instrument and correlates of immune measures.

M. Schiffman, L. McShane, A. Hildesheim, 1999, Journal of immunological methods.

A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation.

M. Sherman, R. Burk, A. Hildesheim, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Human papillomavirus type 16 variants and risk of cervical cancer.

K. Buetow, S. Wacholder, M. Sherman, 2001, Journal of the National Cancer Institute.

A Comparison of Single and Combined Visual , Cytologic , and Virologic Tests as Screening Strategies in a Region at High Risk of Cervical Cancer 1

S. Wacholder, M. Sherman, R. Burk, 2003 .

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

D. Lowy, S. Wacholder, D. Solomon, 2007, JAMA.

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica

S. Wacholder, M. Sherman, M. Schiffman, 2001, British Journal of Cancer.

Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.

M. Sherman, M. Schiffman, R. Burk, 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.

S Wacholder, S. Wacholder, M. Schiffman, 2000, JAMA.

Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.

S. Chanock, S. Wacholder, M. Sherman, 2009, The Journal of infectious diseases.

Common Genetic Variation in TP53 and Risk of Human Papillomavirus Persistence and Progression to CIN3/Cancer Revisited

S. Chanock, M. Yeager, S. Wacholder, 2009, Cancer Epidemiology Biomarkers & Prevention.

Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.

S. Wacholder, M. Sherman, P. Castle, 2005, The Journal of infectious diseases.

Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica.

M. Carrington, C. Wheeler, M. Sherman, 2001, The Journal of infectious diseases.

Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.

M. Carrington, M. Sherman, R. Burk, 2002, The Journal of infectious diseases.

Correlates of IL-10 and IL-12 Concentrations in Cervical Secretions

M. Sherman, K. Shah, A. Hildesheim, 2003, Journal of Clinical Immunology.

Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica.

M. von Knebel Doeberitz, M. Sherman, M. Schiffman, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Utility of liquid‐based cytology for cervical carcinoma screening

M. Sherman, A. Hildesheim, M. Schiffman, 1999, Cancer.

Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica

M. Sherman, M. Schiffman, R. Burk, 2004, British Journal of Cancer.

Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica

M. Sherman, M. Schiffman, P. Castle, 2003, British Journal of Cancer.

Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection

M. Sherman, P. Castle, R. Burk, 2004, Cancer Epidemiology Biomarkers & Prevention.

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.

S. Wacholder, M. Sherman, R. Tarone, 2005, The Journal of infectious diseases.

A study of the impact of adding HPV types to cervical cancer screening and triage tests.

C. Wheeler, S. Wacholder, M. Schiffman, 2005, Journal of the National Cancer Institute.

Comparison of Ophthalmic Sponges for Measurements of Immune Markers from Cervical Secretions

P. Castle, A. Hildesheim, A. Rodriguez, 2004, Clinical Diagnostic Laboratory Immunology.

An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).

M. Sherman, L. Brinton, M. Schiffman, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Short Communication Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica

M. Sherman, P. Castle, R. Burk, 2004 .

Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica

W. Quint, P. Castle, A. Hildesheim, 2007, Journal of Clinical Microbiology.

A population-based study of vaginal human papillomavirus infection in hysterectomized women.

S. Wacholder, M. Sherman, P. Castle, 2004, The Journal of infectious diseases.

L. R. Long, S. Wacholder, R. Pfeiffer, 2006, Cancer research.

Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.

Attila Lorincz, Allan Hildesheim, Sholom Wacholder, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.

M. Carrington, M. Sherman, R. Burk, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Human leukocyte antigen class I and II haplotypes and risk of cervical cancer.

M. Carrington, M. Sherman, M. Schiffman, 2005, Tissue Antigens.

Stability of archived liquid‐based cytologic specimens

P. Castle, A. Hildesheim, M. Schiffman, 2003, Cancer.

Right-Sided Ectocervical Lesions May Be Associated with False-Negative Cytology Among Women with Histologic Cervical Intraepithelial Neoplasia 2 or 3

S. Wacholder, P. Castle, R. Burk, 2003, Journal of lower genital tract disease.

Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography.

M. Schiffman, R. Pfeiffer, P. Castle, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Collection of Cervical Secretions Does Not Adversely Affect Pap Smears Taken Immediately Afterward

M. Schiffman, A. Hildesheim, A. Rodriguez, 1998, Clinical Diagnostic Laboratory Immunology.